ActRIIB:ALK4-Fc alleviates muscle dysfunction and comorbidities in murine models of neuromuscular disorders

Journal: Journal of Clinical Investigation

Published: 2021-02-15

DOI: 10.1172/jci138634

Affiliations: 2

Authors: 21

Go to article
Institutions Share
Acceleron Pharma, Inc., United States of America (USA) 0.90
Barrow Neurological Institute, SJHMC, United States of America (USA) 0.10

Return